Skip to content
The Food and Drug Administration (FDA) on Aug. 6 approved VORANIGO, the first targeted therapy for Grade 2 Isocitrate dehydrogenase (IDH) mutant glioma, a […]
FDA approves Servier’s VORANIGO for certain brain tumors Read More »
Amidst Typhoon Gaemi, the Biotechnology Innovation Organization (BIO) traveled to Taipei to co-host BIO Asia-Taiwan from July 26-30. Luckily, the weather was no match
BIO travels to Taipei to co-host BIO Asia-Taiwan Read More »
Believe it or not, flu season is just around the corner. But with vaccination rates still in decline and the ever-mutating cohort of seasonal
Why getting your flu shot is the right move this fall Read More »
The U.S. is officially in the midst of another summer COVID surge as wastewater levels continue to peak for the second week, with no
The COVID summer surge roundup Read More »
A new report is not only a ringing endorsement of vaccine innovation but also a call for more investment in the vaccine pipeline. The
New report highlights vaccine innovation, need for investment Read More »
Researchers in the Netherlands have reaffirmed the link between influenza infections and the increased, short-term risk of heart attack. The risk is especially elevated
Another reason to get your flu shot? It can reduce your risk of heart attack Read More »
Antimicrobial resistance (AMR) presents a clear threat to human health and healthcare systems. And in the post-COVID era, the threat and calls to address
AMR infections increased 20% during COVID-19 – and continue to pose a threat Read More »
2001 was the dawn of the modern era of biosecurity in the United States. Following the 9/11 attacks and deadly anthrax letters, the nation
A few topics keep popping up in discussions about the future of U.S. healthcare over the past couple of years. The need to pass
3 key priorities shaping the future of U.S. healthcare and biotech Read More »
Biopharma Boehringer Ingelheim took a big step toward achieving the company’s goal of carbon neutrality by 2030 with the July 8 inauguration of a
Boehringer Ingelheim biomass plant cuts drug maker’s carbon footprint Read More »
